Can Acyclovir Increase Anxiety?
Acyclovir is not documented to directly cause anxiety as a primary adverse effect in established clinical guidelines or FDA labeling, though it can cause central nervous system (CNS) symptoms including agitation and neuropsychiatric effects that may manifest as anxiety-like symptoms, particularly in patients with renal impairment or at high doses.
Understanding Acyclovir's Neuropsychiatric Effects
The FDA drug label for acyclovir specifically warns about "reversible central nervous system symptoms" in patients receiving the medication, particularly those with renal dysfunction or on nephrotoxic agents 1. While anxiety is not explicitly listed as a common adverse effect, the documented CNS effects include:
- Agitation (documented in overdose cases) 1
- Neuropsychiatric symptoms (in case reports) 2
- Encephalopathy (rare but documented) 1
The most commonly reported adverse effects in clinical guidelines are nausea and headache 3, not anxiety specifically.
Clinical Context and Risk Factors
When CNS Effects Are Most Likely:
High-risk scenarios include:
- Renal impairment (acyclovir is renally excreted)
- High-dose IV therapy (particularly 8g/day or higher)
- Inadequate hydration
- Concurrent nephrotoxic medications
- Elderly patients with underlying renal dysfunction 1
Evidence from Recent Research:
A 2025 animal study demonstrated that acyclovir at doses of 20-40 mg/kg induced changes in neurotransmitter levels (increased serotonin, decreased dopamine) and increased inflammatory markers in brain tissue 4. While this suggests potential neuropsychiatric mechanisms, this was an animal study at relatively high doses and cannot be directly extrapolated to typical clinical use in humans.
Distinguishing True Anxiety from Disease-Related Distress
Important clinical distinction: The psychological impact of having recurrent genital herpes itself causes substantial anxiety and psychological morbidity. A 1993 study found that 63% of patients with frequently recurring genital herpes met criteria for psychological "cases" on the General Health Questionnaire before starting acyclovir 5.
Critically, acyclovir suppressive therapy actually reduced anxiety: After 3 months of treatment, anxiety cases decreased significantly (p < 0.0001), with sustained improvement throughout the year of treatment 5. This suggests that acyclovir may indirectly reduce anxiety by controlling the underlying infection rather than causing it.
Clinical Recommendations
Monitor for CNS symptoms if:
- Patient has renal impairment (check baseline creatinine, adjust dose accordingly) 1
- Using high-dose IV therapy (monitor renal function 1-2x weekly) 3
- Patient is elderly with potential underlying renal dysfunction 1
- Patient reports new neuropsychiatric symptoms after starting acyclovir
Maintain adequate hydration to reduce risk of crystalluria and nephrotoxicity, which can secondarily cause CNS symptoms 1.
If anxiety or agitation develops:
- Check renal function immediately
- Review acyclovir dosing for appropriateness
- Assess for other causes of anxiety (disease burden, life stressors)
- Consider whether symptoms represent acyclovir neurotoxicity (more likely with confusion, lethargy, or other CNS signs) versus primary anxiety
Bottom Line
Anxiety is not a recognized direct adverse effect of acyclovir in standard therapeutic doses with normal renal function. CNS symptoms can occur, particularly with renal impairment or high doses, but typically manifest as agitation, confusion, or encephalopathy rather than isolated anxiety. The psychological distress from recurrent herpes infections is far more likely to cause anxiety than the acyclovir used to treat it 5.